Technical Analysis for PXXLF - Poxel Sa

Grade Last Price % Change Price Change
grade A 8.29 -0.12% -0.0100
PXXLF closed down 0.12 percent on Monday, October 7, 2019, on 24 percent of normal volume.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent N/A N/A Up
See historical PXXLF trend table...

Date Alert Name Type % Chg
Narrow Range Bar Range Contraction 0.00%
Wide Bands Range Expansion 0.00%
Gapped Down Weakness 0.00%
Narrow Range Bar Range Contraction -0.12%
Wide Bands Range Expansion -0.12%
Gapped Up Strength -0.12%
Stochastic Sell Signal Bearish 0.61%
Narrow Range Bar Range Contraction 0.61%
Wide Bands Range Expansion 0.61%
Overbought Stochastic Strength 0.61%

Older signals for PXXLF ...

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
Poxel SA, a biopharmaceutical company, develops drugs for metabolic diseases with a primary focus on type II diabetes. Its lead product is Imeglimin, an oral anti-diabetic candidate, which is in Phase III clinical development stage that targets the organs of diabetes, such as pancreas, liver, and muscles. The company is also developing PXL770, an adenosine monophosphate-activated protein kinase enzyme, which is in Phase IIa clinical trial that controls body energy metabolism and treats chronic metabolic diseases, such as non-alcoholic steatohepatitis. Poxel SA has a licensing agreement with Enyo Pharmaceuticals for the development of PXL007 (EYP001), an FXR agonist that is in Phase I study for the treatment of Hepatitis B. The company was founded in 2009 and is headquartered in Lyon, France.
Medicine RTT Biopharmaceutical Diabetes Metabolic Diseases Diabetes Mellitus Hepatitis Metabolism Hepatitis B Ii Diabetes Steatohepatitis Non Alcoholic Fatty Liver Disease
Is PXXLF a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 1 bullish, 0 bearish and 4 neutral indicators. You may wish to incorporate that into your trading strategies.
Recent News
Indicators
Indicator Value
52 Week High 9.6968
52 Week Low 5.85
Average Volume 1,638
200-Day Moving Average 0.0
50-Day Moving Average 0.0
20-Day Moving Average 7.8476
10-Day Moving Average 8.125
Average True Range 0.412
ADX 13.3
+DI 47.6616
-DI 43.6783
Chandelier Exit (Long, 3 ATRs ) 8.264
Chandelier Exit (Short, 3 ATRs ) 7.886
Upper Bollinger Band 9.3883
Lower Bollinger Band 6.3069
Percent B (%b) 0.64
BandWidth 39.265508
MACD Line 0.1721
MACD Signal Line 0.1043
MACD Histogram 0.0678
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 8.2900
Resistance 3 (R3) 8.2900 8.2900 8.2900
Resistance 2 (R2) 8.2900 8.2900 8.2900 8.2900
Resistance 1 (R1) 8.2900 8.2900 8.2900 8.2900 8.2900
Pivot Point 8.2900 8.2900 8.2900 8.2900 8.2900
Support 1 (S1) 8.2900 8.2900 8.2900 8.2900 8.2900
Support 2 (S2) 8.2900 8.2900 8.2900 8.2900
Support 3 (S3) 8.2900 8.2900 8.2900
Support 4 (S4) 8.2900